Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Burgess

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Kidney International|May 23, 2008
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathyGeorge Bakris, Ellen Burgess, Matthew Weir, et al.
Vascular Health and Risk Management|October 3, 2018
Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved dosesMireille Fernet, Bruce Beckerman, Paula Abreu, et al.
Journal of the American Society of Nephrology : JASN|February 13, 2009
Supramaximal dose of candesartan in proteinuric renal diseaseEllen Burgess, Norman Muirhead, Paul Rene de Cotret, et al.
Gynecologic Oncology|February 1, 2024
Critical decisions: A mixed-methods study of decision-making among diverse gynecologic cancer patients considering therapeutic clinical trial enrollmentStephanie Margrit Rieder, Ellen Burgess, Teresa Rutledge, et al.
American Journal of Community Psychology|April 6, 2021
CBPR Implementation Framework for Community-Academic PartnershipsVictoria Sánchez, Shannon Sanchez-Youngman, Elizabeth Dickson, et al.
BMC Psychiatry|April 20, 2011
Systematic review of safety and tolerability of a complex micronutrient formula used in mental healthJ Steven A Simpson, Susan G Crawford, Estelle T Goldstein, et al.
The Canadian Journal of Cardiology|January 9, 2003
Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney diseaseJacques LeLorier, Claire Bombardier, Ellen Burgess, et al.
Cancer Causes & Control : CCC|July 13, 2022
Patient, provider, and nurse preferences of patient reported outcomes (PRO) and side effect management during cancer treatment of underrepresented racial and ethnic minority groups, rural and economically disadvantaged patients: a mixed methods studyBernard Tawfik, Ellen Burgess, Mikaela Kosich, et al.
JAMA|February 2, 2002
Chelation therapy for ischemic heart disease: a randomized controlled trialMerril L Knudtson, D George Wyse, P Diane Galbraith, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|May 22, 2020
Engage for Equity: Development of Community-Based Participatory Research ToolsMyra Parker, Nina Wallerstein, Bonnie Duran, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Kidney International|May 23, 2008
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathyGeorge Bakris, Ellen Burgess, Matthew Weir, et al.
Vascular Health and Risk Management|October 3, 2018
Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved dosesMireille Fernet, Bruce Beckerman, Paula Abreu, et al.
Journal of the American Society of Nephrology : JASN|February 13, 2009
Supramaximal dose of candesartan in proteinuric renal diseaseEllen Burgess, Norman Muirhead, Paul Rene de Cotret, et al.
Gynecologic Oncology|February 1, 2024
Critical decisions: A mixed-methods study of decision-making among diverse gynecologic cancer patients considering therapeutic clinical trial enrollmentStephanie Margrit Rieder, Ellen Burgess, Teresa Rutledge, et al.
American Journal of Community Psychology|April 6, 2021
CBPR Implementation Framework for Community-Academic PartnershipsVictoria Sánchez, Shannon Sanchez-Youngman, Elizabeth Dickson, et al.
BMC Psychiatry|April 20, 2011
Systematic review of safety and tolerability of a complex micronutrient formula used in mental healthJ Steven A Simpson, Susan G Crawford, Estelle T Goldstein, et al.
The Canadian Journal of Cardiology|January 9, 2003
Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney diseaseJacques LeLorier, Claire Bombardier, Ellen Burgess, et al.
Cancer Causes & Control : CCC|July 13, 2022
Patient, provider, and nurse preferences of patient reported outcomes (PRO) and side effect management during cancer treatment of underrepresented racial and ethnic minority groups, rural and economically disadvantaged patients: a mixed methods studyBernard Tawfik, Ellen Burgess, Mikaela Kosich, et al.
JAMA|February 2, 2002
Chelation therapy for ischemic heart disease: a randomized controlled trialMerril L Knudtson, D George Wyse, P Diane Galbraith, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|May 22, 2020
Engage for Equity: Development of Community-Based Participatory Research ToolsMyra Parker, Nina Wallerstein, Bonnie Duran, et al.
Pageof 5